Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn
Mankind Pharma has announced a definitive agreement for the acquisition of a 100% stake in Bharat Serums and Vaccines (BSV)…
Mankind Pharma has announced a definitive agreement for the acquisition of a 100% stake in Bharat Serums and Vaccines (BSV)…
Ipsen is looking to expand its paediatric medication portfolio and has signed a licensing agreement potentially worth $461m with Day…
AstraZeneca has signed a licensing agreement with Pinetree Therapeutics for a preclinical epidermal growth factor receptor (EGFR) degrader candidate, potentially…
Agilent Technologies has announced a definitive agreement for the acquisition of Canadian contract development and manufacturing organisation (CDMO) BIOVECTRA in…
Grünenthal has announced the acquisition of US-based Valinor Pharma, along with its opioid-induced constipation (OIC) therapy Movantik, in a $250m…
Exscientia has taken full ownership of an oral cyclin-dependent kinase 7 (CDK7) inhibitor after buying out its development partner GT…
SOTIO Biotech has signed a research and licensing agreement with China-based Biocytogen to develop multiple bispecific antibody-drug conjugate (ADC) candidates…
Clinical-stage biotech company Asceneuron has announced an oversubscribed Series C financing round, securing $100m for advancing therapeutics in neurodegenerative diseases.…
AstraZeneca has closed the acquisition of Amolyt Pharma, a company specialising in treatments for rare endocrine diseases. The deal between…
Two months after MSD (Merck & Co) set its eye on acquiring Eyebiotech (EyeBio), the former has closed the deal,…